Latest filing published 23 Aug 2021 for Oncopeptides AB, €8,044.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Anders Martin-Löf: trading record in brief
This profile gathers the share dealings of Anders Martin-Löf in Oncopeptides AB. We count 4 filings; the first trade dates from 26 September 2019 and the latest from 23 August 2021.
On the market, this insider has only ever bought: 4 purchases, €64k in total. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Since January 2021: 3 purchases and no sales on the market.
The median purchase comes to €17k.
Most recently, on 23 August 2021, the filings show an open-market purchase worth €8,044 in Oncopeptides AB. Half of the filings or more reach the Finansinspektionen feed on the day of the trade. The legal deadline for notifying a trade is three business days (MAR article 19). This summary is built from Finansinspektionen disclosures alone and does not predict where the share price will go.
Companies and markets linked to Anders Martin-Löf
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,000 shares@ SEK 41.177AktieISIN SE0009414576FI:csv-4bd0967c22b4cdc8a9cfCanonical exit: 21 Nov 2021 (T+90)
- 2,000 shares@ SEK 102.092AktieISIN SE0009414576FI:csv-18b95c14be0e89408be8Canonical exit: 24 Aug 2021 (T+90)
- 1,000 shares@ SEK 137.62AktieISIN SE0009414576FI:csv-02b0d293404a9ef3dda3Canonical exit: 27 Jun 2021 (T+90)
- 2,000 shares@ SEK 119.18AktieISIN SE0009414576FI:csv-4b14d7f7ae786897a340Canonical exit: 25 Dec 2019 (T+90)
4 of 4 declarations